Login
Get Started
Today
Browse
Screens
Folios
Discuss
Learn
Browse
Shares
Healthcare
Biotechnology & Medical Research
Zogenix Inc
ZGNX -
Zogenix Inc
Share News
$22.16
-1.3 -5.4%
Last Trade -
9:00pm
Sector
Healthcare
RiskRating
Adventurous
Size
Mid Cap
Style
Sucker Stock
Market Cap
£922.6m
Enterprise Value
£641.6m
Revenue
£5.01m
Position in Universe
2571st / 6713
Quality
Value
Momentum
Stock
Rank™
StockReport™
Tools
Compare with...
Run through checklist
Accounts
Balance sheet
Income statement
Cashflow statement
Dividend summary
Charts
News
Discussions
ZGNX Dividends
All News
All News
Reuters News
Company Announcements
BRIEF-Zogenix Reports Q4 And Full-Year 2020 Financial Results
43 mins ago
News
Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
9:01pm
News
Zogenix to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
18th Feb
News
Zogenix to Release Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call and Webcast on February 25
11th Feb
News
BRIEF-Zogenix's Fintepla® (Fenfluramine) Oral Solution Now Available In Germany For Treatment Of Seizures In Dravet Syndrome
1st Feb
News
Zogenix’s FINTEPLA® (Fenfluramine) Oral Solution Now Available in Germany for the Treatment of Seizures in Dravet Syndrome
1st Feb
News
BRIEF-Zogenix Announces Preliminary, Unaudited Q4 2020 Net Product Sales
11th Jan
News
Zogenix Announces Preliminary, Unaudited Fourth Quarter 2020 Net Product Sales
11th Jan
News
BRIEF-Zogenix - European Commission Approves Co's Fintepla Oral Solution For Treatment Of Seizures In Dravet Syndrome
21st Dec '20
News
The European Commission Approves Zogenix’s FINTEPLA® (Fenfluramine) Oral Solution for the Treatment of Seizures in Dravet Syndrome
21st Dec '20
News
BRIEF-Tevard Biosciences And Zogenix Announce Collaboration To Advance Novel Gene Therapies For Dravet Syndrome And Other Genetic Epilepsies
3rd Dec '20
News
Zogenix and Leading Experts to Present New Rare Epilepsy Data at AES 2020
1st Dec '20
News
Zogenix to Participate in the Stifel 2020 Virtual Healthcare Conference
11th Nov '20
News
BUZZ-Zogenix: Falls on bigger-than-expected Q3 loss
10th Nov '20
News
BRIEF-Zogenix Reports Q3 Loss Per Share $1.08
9th Nov '20
News
Zogenix Provides Corporate Update and Reports Third Quarter 2020 Financial Results
9th Nov '20
News
Zogenix Announces Date Change for Third Quarter 2020 Financial Results and Conference Call and Webcast to November 9
29th Oct '20
News
Zogenix to Release Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 10
26th Oct '20
News
BRIEF-Zogenix Receives Positive CHMP Opinion For Fintepla
16th Oct '20
News
Zogenix Receives Positive CHMP Opinion for FINTEPLA® (Fenfluramine) Oral Solution for the Treatment of Seizures in Patients with Dravet Syndrome
16th Oct '20
News
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next »
Unlock the metrics for all these stocks and more...
Unlock
with Google
Unlock with Facebook
Unlock with Email
Unlock
with Google
Unlock
with Facebook
or
Unlock with your email
© Stockopedia 2021, Refinitiv, Share Data Services.
Facebook
Twitter
Youtube
Instagram
RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our
Terms of Use
,
Privacy
and
Disclaimer
policies.
Unlock the metrics for all these stocks and more...
Unlock
with Google
Unlock with Facebook
Unlock with Email
Unlock
with Google
Unlock
with Facebook
or
Unlock with your email